The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Chen, Qiyi ^a   Yu, Wenkui ^a   Shi, Jiangliang ^a   Shen, Juanhong ^a   Hu, Yimin ^a   Gao, Tao ^a   Zhang, Juanjuan ^a   Xi, Fengchan ^a   Gong, Jianfeng ^a   Li, Jieshou ^a   Li, Ning ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Adult respiratory distress syndrome; Extra corporeal membrane oxygenation; Immune inflammatory response; Neurological impairment

Indexed keywords

CYTOKINE;

ANIMAL; ARTICLE; BLOOD; BRAIN LEVEL; ENCEPHALITIS; EXTRACORPOREAL OXYGENATION; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; SWINE;

ANIMALS; BRAIN CHEMISTRY; CYTOKINES; ENCEPHALITIS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; MALE; SWINE;

EID: 84883116726     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-186     Document Type: Article

References (39)

1. Hill JD, O'Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 1972, 286(12):629-634. 10.1056/NEJM197203232861204, 5060491.
2. Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011, 306(15):1659-1668. 10.1001/jama.2011.1471, 21976615.
3. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374(9698):1351-1363. 10.1016/S0140-6736(09)61069-2, 19762075.
4. Beiderlinden M, Eikermann M, Boes T, Breitfeld C, Peters J. Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange. Intensive Care Med 2006, 32(10):1627-1631. 10.1007/s00134-006-0262-y, 16874497.
5. Mols G, Loop T, Geiger K, Farthmann E, Benzing A. Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg 2000, 180(2):144-154. 10.1016/S0002-9610(00)00432-3, 11044532.
6. Bickenbach J, Biener I, Czaplik M, et al. Neurological outcome after experimental lung injury. Respir Physiol Neurobiol 2011, 179(2-3):174-180.
7. Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med 1999, 160(1):50-56. 10.1164/ajrccm.160.1.9708059, 10390379.
8. Guenther U, Varelmann D, Putensen C, Wrigge H. Extended therapeutic hypothermia for several days during extracorporeal membrane-oxygenation after drowning and cardiac arrest Two cases of survival with no neurological sequelae. Resuscitation 2009, 80(3):379-381. 10.1016/j.resuscitation.2008.11.019, 19150159.
9. Bembea MM, Savage W, Strouse JJ, et al. Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation. Pediatr Crit Care Med 2011, 12(5):572-579. 10.1097/PCC.0b013e3181fe3ec7, 3686089, 21057367.
10. Bulas D, Glass P. Neonatal ECMO: neuroimaging and neurodevelopmental outcome. Semin Perinatol 2005, 29(1):58-65. 10.1053/j.semperi.2005.02.009, 15921154.
11. Risnes I, Wagner K, Nome T, et al. Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation. Ann Thorac Surg 2006, 81(4):1401-1406. 10.1016/j.athoracsur.2005.10.008, 16564280.
12. McILwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 2010, 90(1):128-139. 10.1038/labinvest.2009.119, 2799549, 19901912.
13. Kurundkar AR, Killingsworth CR, McIlwain RB, et al. Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet. Pediatr Res 2010, 68(2):128-133. 10.1203/PDR.0b013e3181e4c9f8, 2914515, 20442689.
14. Stolp HB, Dziegielewska KM. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 2009, 35(2):132-146. 10.1111/j.1365-2990.2008.01005.x, 19077110.
15. Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F. Neuronal damage in brain inflammation. Arch Neurol 2007, 64(2):185-189. 10.1001/archneur.64.2.185, 17296833.
16. Jiang W, Desjardins P, Butterworth RF. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J Neurochem 2009, 109(2):485-493. 10.1111/j.1471-4159.2009.05981.x, 19220703.
17. Nimmo AJ, Cernak I, Heath DL, Hu X, Bennett CJ, Vink R. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 2004, 38(1):40-47. 10.1016/j.npep.2003.12.003, 15003715.
18. Denes A, Thornton P, Rothwell NJ, Allan SM. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2010, 24(5):708-723. 10.1016/j.bbi.2009.09.010, 19770034.
19. Yang MS, Min KJ, Joe E. Multiple mechanisms that prevent excessive brain inflammation. J Neurosci Res 2007, 85(11):2298-2305. 10.1002/jnr.21254, 17348044.
20. Lidegran MK, Mosskin M, Ringertz HG, Frenckner BP, Linden VB. Cranial CT for diagnosis of intracranial complications in adult and pediatric patients during ECMO: Clinical benefits in diagnosis and treatment. Acad Radiol 2007, 14(1):62-71. 10.1016/j.acra.2006.10.004, 17178367.
21. Mildner RJ, Taub N, Vyas JR, et al. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate 2005, 88(4):321-327. 10.1159/000087630, 16113527.
22. Elmquist JK, Scammell TE, Saper CB. Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurosci 1997, 20(12):565-570. 10.1016/S0166-2236(97)01138-7, 9416669.
23. Banks WA, Ortiz L, Plotkin SR, Kastin AJ. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991, 259(3):988-996.
24. Webb AA, Muir GD. The blood-brain barrier and its role in inflammation. J Vet Intern Med 2000, 14(4):399-411. 10.1111/j.1939-1676.2000.tb02248.x, 10935890.
25. Ransohoff RM, Tani M. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation. Trends Neurosci 1998, 21(4):154-159. 10.1016/S0166-2236(97)01198-3, 9554725.
26. Duchini A, Govindarajan S, Santucci M, Zampi G, Hofman FM. Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Investig Med 1996, 44(8):474-482.
27. Deli MA, Descamps L, Dehouck MP, et al. Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res 1995, 41(6):717-726. 10.1002/jnr.490410602, 7500373.
28. Stroemer RP, Rothwell NJ. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J Cereb Blood Flow Metab 1998, 18(8):833-839.
29. Van DAM, Brouns M, Louisse S, Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness. Brain Res 1992, 588(2):291-296. 10.1016/0006-8993(92)91588-6, 1393581.
30. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992, 29(2):243-246. 10.1016/0361-9230(92)90033-T, 1388088.
31. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000, 20(2):131-147. 10.1023/A:1007074420772, 10696506.
32. Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 2004, 10(4):201-222.
33. Dunn AJ. Cytokine activation of the HPA axis. Ann N Y Acad Sci 2000, 917:608-617.
34. Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 2006, 6(1-2):52-68. 2136407, 18079991.
35. Jeter CB, Hergenroeder GW, Hylin MJ, Redell JB, Moore AN, Dash PK. Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion. J Neurotrauma 2013, 30(8):657-670. 10.1089/neu.2012.2439, 23062081.
36. Papa L, Ramia MM, Kelly JM, Burks SS, Pawlowicz A, Berger RP. Systematic Review of Clinical Research on Biomarkers for Pediatric Traumatic Brain Injury. J Neurotrauma 2013, 30(5):324-338. 10.1089/neu.2012.2545, 23078348.
37. Barrett CS, Bratton SL, Salvin JW, Laussen PC, Rycus PT, Thiagarajan RR. Neurological injury after extracorporeal membrane oxygenation use to aid pediatric cardiopulmonary resuscitation. Pediatr Crit Care Med 2009, 10(4):445-451. 10.1097/PCC.0b013e318198bd85, 19451851.
38. Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 2008, 13(2):208-221. 10.1038/sj.mp.4002042, 17579604.
39. Londono D, Carvajal J, Strle K, Kim KS, Cadavid D. IL-10 Prevents apoptosis of brain endothelium during bacteremia. J Immunol 2011, 186(12):7176-7186. 10.4049/jimmunol.1100060, 21602495.